Search Results - "Hamann, Philip D."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis by Hamann, Philip D., Roux, Benoit T., Heward, James A., Love, Seth, McHugh, Neil J., Jones, Simon W., Lindsay, Mark A.

    Published in Scientific reports (14-08-2017)
    “…Myositis is characterised by muscle inflammation and weakness. Although generally thought to be driven by a systemic autoimmune response, increasing evidence…”
    Get full text
    Journal Article
  2. 2

    Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA by Hamann, Philip D H, Pauling, John D, McHugh, Neil, Hyrich, Kimme, Shaddick, Gavin

    Published in Rheumatology (Oxford, England) (01-07-2020)
    “…Abstract Objective To identify different trajectories of disease activity in patients with RA following initiation of a first anti-TNF. Methods Patients with…”
    Get full text
    Journal Article
  3. 3

    Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis by Hamann, Philip D H, Shaddick, Gavin, Hyrich, Kimme, Green, Amelia, McHugh, Neil, Pauling, John D

    Published in Rheumatology (Oxford, England) (01-05-2019)
    “…Abstract Objectives To evaluate determinants of discordance between DAS28-ESR and DAS28-CRP and resulting impact on disease activity stratification in RA…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients by Hamann, Philip D H, Pauling, John D, McHugh, Neil, Shaddick, Gavin, Hyrich, Kimme

    Published in Rheumatology (Oxford, England) (01-12-2019)
    “…Abstract Objectives To investigate the frequency and predictors of sustained 28-joint DAS (DAS28) remission and low disease activity (LDA) in patients…”
    Get full text
    Journal Article
  6. 6

    Statin-induced necrotizing myositis – A discrete autoimmune entity within the “statin-induced myopathy spectrum” by Hamann, Philip D.H, Cooper, Robert G, McHugh, Neil J, Chinoy, Hector

    Published in Autoimmunity reviews (01-10-2013)
    “…Abstract Statin-induced necrotizing myositis is increasingly being recognised as part of the “statin-induced myopathy spectrum”. As in other immune-mediated…”
    Get full text
    Journal Article
  7. 7
  8. 8

    P053 Patient engagement in long-term PROMs collection: 48-month observation in real-world clinical practice by Biliavska, Iuliia, Lenguerrand, Erik, Sparey, Esme, Tobias, Jon H, Hamann, Philip D H

    Published in Rheumatology (Oxford, England) (24-04-2023)
    “…Abstract Background/Aims Patient-reported outcome measures (PROMs) allow effective communication of disease experiences and encourage shared decision-making…”
    Get full text
    Journal Article
  9. 9

    P104 Longitudinal patient reported outcome data collected from a smartphone app can map group level trajectories of disease activity over time by Hamann, Philip D. H, Minaur, Nicola, Tobias, Jon H, Clark, Emma M

    Published in Rheumatology (Oxford, England) (01-04-2020)
    “…Abstract Background Patient-reported outcome measures are a cornerstone of the current early inflammatory arthritis audit and part of the best practice tariff…”
    Get full text
    Journal Article
  10. 10